Dosage for Older Adults : For older adults, starting with 500 mg per day and gradually increasing to 1,000 mg over several weeks can help improve glutathione deficiency and minimise side effects
Semaglutide has shown superior weight loss outcomes compared to other medications and diet-based approaches, providing a more effective and long-lasting solution
For individuals with diabetes and overweight or obesity, the ADA recommends as preferred pharmacotherapy a GLP-1 receptor agonist or a dual GLP-1/GIP receptor agonist with substantial weight-loss efficacy, meaning semaglutide or tirzepatide
Genetic variation in selenoprotein S influences inflammatory response
In the SURPASS clinical trial program, tirzepatide reduced HbA1c by 2.0-2.4% depending on dose, bringing the majority of participants to target levels below 7.0%
This follow-up allows our providers to fine-tune dosing strategies, provide encouragement, and answer questions